[ad_1]
However, over the next year, production and deliveries of this vaccine are expected to increase substantially.
BioNTech expects to start production in Germany in February, at a factory in Marburg. Facilities that were acquired in September and that, once full, will have the capacity to produce 750 million doses per year.
For Portugal, the Minister of Health, Marta Temido, said last week that the country should receive between December 2020 and January 2021 about 300 thousand doses.
By the first quarter of 2021, Portugal expects to receive around 1.2 million doses of the Pfizer-BioNTech vaccine against Covid-19.
Also this morning, BioNTech officials ensured that, If necessary, the pharmacist can provide another vaccine “in six weeks” to respond to possible mutations of the virus, as happened in the United Kingdom.
“In principle, the beauty of messenger RNA technology is that we can directly start designing a vaccine that completely mimics the new mutation,” said scientist and entrepreneur Ugur Sahin of the German laboratory BioNTech.
